Cvs Pharmacy #06178 Durable Medical Equipment & Medical Supplies Location: 143 E Sandusky Ave, Bellefontaine, Ohio 43311 Phone: (937) 593-1040 |
Rite Aid Pharmacy 04767 Durable Medical Equipment & Medical Supplies Location: 230 S Main St, Bellefontaine, Ohio 43311 Phone: (937) 599-2314 |
Walmart Pharmacy 10-1264 Durable Medical Equipment & Medical Supplies Location: 2281 Us Hwy 68 S, Bellefontaine, Ohio 43311 Phone: (937) 592-5000 |
Kroger Pharmacy Durable Medical Equipment & Medical Supplies Location: 2129 S Main St, Bellefontaine, Ohio 43311 Phone: (937) 592-3464 |
Walgreens #10915 Durable Medical Equipment & Medical Supplies Location: 101 E Sandusky Ave, Bellefontaine, Ohio 43311 Phone: (937) 292-8104 |
Logan View Llc Durable Medical Equipment & Medical Supplies Location: 110 Dowell Ave, Bellefontaine, Ohio 43311 Phone: (937) 593-2100 |
Rush Optical Medicare Supplier Location: 1107 Rush Ave, Bellefontaine, Ohio 43311 Phone: (937) 593-5735 |
Professional Vision Services Medicare Supplier Location: 1711 S Main St, Bellefontaine, Ohio 43311 Phone: (937) 592-5005 |
North Main Eyecare Llc Medicare Supplier Location: 1008 N Main St, Bellefontaine, Ohio 43311 Phone: (937) 599-5318 |
News Archive
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog to accelerate platelet recovery and improve survival in a mouse model of Acute Radiation Syndrome (ARS).
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium, has received its CE mark. This means it is approved for professional use in the UK and EU.
Abbott and Bristol-Myers Squibb Company today announced interim results from the Phase 2 portion of a Phase 1b/2 open-label study which showed a high objective response rate (ORR) among patients with relapsed multiple myeloma who received elotuzumab plus lenalidomide and low-dose dexamethasone.
Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.
Two studies published in a recent issue of Cell Medicine report on the therapeutic efficacy of stem cell transplantation in animal models of amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI).
› Verified 9 days ago